Soc. Generale Discount Zert NDA 2.../ DE000SQ75BH8 /
31/05/2024 21:45:02 | Chg.-0.090 | Bid21:59:51 | Demandez à21:59:51 | Sous-jacent | Prix d'exercice | Date d'expiration | Type d'option |
---|---|---|---|---|---|---|---|
77.170EUR | -0.12% | 77.600 Bid taille: 200 |
78.000 Ask la taille: 200 |
AURUBIS AG | - EUR | 28/06/2024 | Call |
GlobeNewswire
02/06
Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
GlobeNewswire
02/06
Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 202...
GlobeNewswire
02/06
KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering
GlobeNewswire
02/06
Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Ear...
GlobeNewswire
02/06
Precede Biosciences Presents New Data at ASCO 2024 Demonstrating Accurate HER2 Status Detection Acro...
GlobeNewswire
02/06
ALX Oncology Presents First Evorpacept Combination Data with an Antibody-Drug Conjugate from Phase 1...
GlobeNewswire
02/06
Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT...
GlobeNewswire
02/06
BIIB INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Biogen, Inc. Investors with Sub...
GlobeNewswire
02/06
Celldex Therapeutics Presents Data Demonstrating Profound Improvements in Angioedema in Barzolvolima...
GlobeNewswire
02/06
NVIDIA Enables Real-Time Healthcare, Industrial and Scientific AI Applications at the Edge With Ente...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page